Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats

[1]  C. Ruiz,et al.  A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition , 2023, bioRxiv.

[2]  S. Hauser,et al.  CNO Administration Increases Dopamine and Glutamate in the Medial Prefrontal Cortex of Wistar Rats: Further Concerns for the Validity of the CNO-activated DREADD Procedure , 2022, Neuroscience.

[3]  L. Vanderschuren,et al.  Increased elasticity of sucrose demand during hyperdopaminergic states in rats , 2022, Psychopharmacology.

[4]  L. Chandler,et al.  Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats , 2021, Scientific Reports.

[5]  V. Coizet,et al.  Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats , 2020, bioRxiv.

[6]  Samuel T. Slocum,et al.  Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys , 2019, Nature Neuroscience.

[7]  Ara M. Abramyan,et al.  High-potency ligands for DREADD imaging and activation in rodents and monkeys , 2019, Nature Communications.

[8]  V. Coizet,et al.  DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands , 2019, eNeuro.

[9]  N. Wu,et al.  Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice , 2019, Metabolic Brain Disease.

[10]  Hedok Lee,et al.  The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels , 2019, Front. Neurosci..

[11]  D. Kullmann,et al.  Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics , 2019, Science Advances.

[12]  D. Bartsch,et al.  Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral Neuroscience , 2018, Front. Behav. Neurosci..

[13]  Reid H. J. Olsen,et al.  DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo , 2018, ACS pharmacology & translational science.

[14]  Philip G. F. Browning,et al.  Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys , 2018, The Journal of Neuroscience.

[15]  A. Petersen,et al.  Locomotor- and Reward-Enhancing Effects of Cocaine Are Differentially Regulated by Chemogenetic Stimulation of Gi-Signaling in Dopaminergic Neurons , 2018, eNeuro.

[16]  Brittney M. Cox,et al.  Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse , 2018, The Journal of Neuroscience.

[17]  Brandon K. Harvey,et al.  Chemogenetics revealed: DREADD occupancy and activation via converted clozapine , 2017, Science.

[18]  Linde Boekhoudt,et al.  Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats , 2016, European Neuropsychopharmacology.

[19]  Prachi Khare,et al.  Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments , 2016, eNeuro.

[20]  N. Swerdlow,et al.  Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration , 2007, Pharmacology Biochemistry and Behavior.

[21]  B. Roth,et al.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand , 2007, Proceedings of the National Academy of Sciences.

[22]  T. Hyphantis,et al.  d-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats , 1998, Neuroscience & Biobehavioral Reviews.

[23]  Patrick Aldrin-Kirk,et al.  Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain. , 2019, Methods in molecular biology.

[24]  W. Honig,et al.  Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat , 2004, Psychopharmacologia.